This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
IESE Insight. Número 10. Tercer trimestre 2011
IESE InsightMagazine REV-10Economics, Finance, Innovation and Change, Knowledge and Communication, Leadership and People Management, Marketing, Service and Operations Management, StrategyHoy, las empresas que piensan en internacionalizarse, innovar y crecer tienen muy claro que deben dirigirse a los mercados que llamábamos emergentes, y que ahora se conocen como de alto crecimiento. Pero las realidades de estos mercados ya no son como hace una década. Los artículos de este número de IESE Insight apuntan algunos aspectos que las empresas harían bien en tener en cuenta. Mauro F. Guillen y Esteban García-Canal repasan la...Starting at €22.00
-
Provein: Decisiones en la Gestión de Stocks
Garrido Martínez, EnriqueCase IIST-PI-121Information Technologies, Service and Operations ManagementPROVEIN era una pequeña empresa sevillana que se dedicaba a la venta al detalle de piezas de recambio para vehículos industriales. En el momento del caso se encontraba en una situación complicada, debido a la bajada de la actividad económica y, por lo tanto, al incremento de la presión competitiva. Adicionalmente, los proveedores del sector (multinacionales) habían ido cerrando sus almacenes en España, para pasar a servir desde Centroeuropa y los...Starting at €8.20
-
Las dificultades del cambio: el modelo de Seguridad Social nicaragüense en transición
La Forgia G. M.; Ribera, Jaume; Rosenmöller, MagdaCase P-1009Service and Operations ManagementUn consultor contratado para preparar un informe examinando la viabilidad de la aplicación de un esquema similar al del MSP (Modelo de Salud Provisional, ya funcionando dentro del INSS - Instituto Nicaragüense de Seguridad Social) a poblaciones pobres no cubiertas por el INSS, llega a la conclusión que el esquema aún no puede ser transferido ya que puede requerir mejoras urgentes e importantes. El caso describe el progreso del MSP: crecimiento de...Starting at €8.20
-
Growing pains: the Nicaraguan social insurance health model in transition
La Forgia G. M.; Ribera, Jaume; Rosenmöller, MagdaCase P-1009-EService and Operations ManagementA consultant who has been contracted to draw up a report examining the feasibility of applying a model similar to that of the MSP (provisional health model, already operating within the INSS - Nicaraguan Institute of Social Security) to poor populations not covered by the INSS, reaches the conclusion that the model is not yet transferable as it may require urgent large-scale improvements. The case describes the MSP's progress: a 160% growth in th...Starting at €8.20
-
The Flower and the Volcano: How Eyajafjallajökull Disrupted Kenya's Flower Industry
Chaturvedi, Aadhaar; Martínez de Albéniz, VictorCase P-1106-EService and Operations ManagementOn the morning of April 19, 2010, Mr. Eduard Ngugi, the manager of the Uraidi rose farm, was considering what to do with the roses that had filled the cold storage for the past 2 days. By this time, the roses, sitting in the cold storage room on the shore of Lake Naivasha, Kenya, should have found their way into the homes of western European customers. However, the explosive eruption in Iceland of the Eyjafjallajökull volcano on April 14 had grou...Starting at €8.20
-
BYD Company, Ltd., Teaching Note
Huckman, Robert S.Teaching Note HBS-610073-EService and Operations ManagementTeaching Note for [606139].Starting at €0.00
-
Bill & Melinda Gates Foundation: Shaping the Vaccine Manufacturing Ecosystem (Abridged)
Shih, WillyCase HBS-620071-EService and Operations ManagementThis case describes the efforts of the Bill & Melinda Gates Foundation to lower the cost of production of vaccines to prevent polio infections. It is an abridged version of Case No. 620-021 with less emphasis on comparison between traditional and the new compact modular process developed with the Foundation's funding. It focuses more on the lowering of entry barriers to vaccine manufacture and some of the perceived risks associated with that.Starting at €8.20